These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24420714)

  • 1. Bioactive poly(arsenic) compounds.
    Mancini I; Defant A
    Prog Mol Subcell Biol; 2013; 54():175-95. PubMed ID: 24420714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite.
    Liu J; Lu Y; Wu Q; Goyer RA; Waalkes MP
    J Pharmacol Exp Ther; 2008 Aug; 326(2):363-8. PubMed ID: 18463319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide in the management of acute promyelocytic leukaemia.
    Mathews V; Chandy M; Srivastava A
    Natl Med J India; 2001; 14(4):215-22. PubMed ID: 11547528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The medicinal use of realgar (As₄S₄) and its recent development as an anticancer agent.
    Wu J; Shao Y; Liu J; Chen G; Ho PC
    J Ethnopharmacol; 2011 Jun; 135(3):595-602. PubMed ID: 21497649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
    Sui M; Zhang Z; Zhou J
    Chin Med J (Engl); 2014; 127(19):3503-6. PubMed ID: 25269921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic compounds: revived ancient remedies in the fight against human malignancies.
    Liu JX; Zhou GB; Chen SJ; Chen Z
    Curr Opin Chem Biol; 2012 Apr; 16(1-2):92-8. PubMed ID: 22342767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
    Verstovsek S; Giles F; Quintás-Cardama A; Perez N; Ravandi-Kashani F; Beran M; Freireich E; Kantarjian H
    Hematol Oncol; 2006 Dec; 24(4):181-8. PubMed ID: 16783836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic in medicine: past, present and future.
    Paul NP; Galván AE; Yoshinaga-Sakurai K; Rosen BP; Yoshinaga M
    Biometals; 2023 Apr; 36(2):283-301. PubMed ID: 35190937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
    Douer D; Tallman MS
    J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances on effect of arsenic trioxide on tumor].
    Feng CQ; Ma WL; Zheng WL
    Ai Zheng; 2002 Dec; 21(12):1386-9. PubMed ID: 12520754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
    Leu L; Mohassel L
    Am J Health Syst Pharm; 2009 Nov; 66(21):1913-8. PubMed ID: 19850784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute promyelocytic leukemia with arsenic trioxide.
    Conrad ME
    N Engl J Med; 1999 Apr; 340(13):1043-5. PubMed ID: 10189286
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
    Perreault S; Moeller J; Patel K; Eyler R; Pham T; Russell K; Podoltsev N
    J Oncol Pharm Pract; 2016 Aug; 22(4):646-51. PubMed ID: 25972392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
    Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
    Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic prepared by Chinese alchemist-pharmacists.
    Zhu J; Ren D
    Sci China Life Sci; 2016 Oct; 59(10):1086-1089. PubMed ID: 27687865
    [No Abstract]   [Full Text] [Related]  

  • 16. Darinaparsin: a novel organic arsenical with promising anticancer activity.
    Mann KK; Wallner B; Lossos IS; Miller WH
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
    Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
    Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
    Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
    Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological responses to arsenic compounds.
    Platanias LC
    J Biol Chem; 2009 Jul; 284(28):18583-7. PubMed ID: 19363033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.